Cargando…

IL-12 and GM-CSF in DNA/MVA Immunizations against HIV-1 CRF12_BF Nef Induced T-Cell Responses With an Enhanced Magnitude, Breadth and Quality

In Argentina, the HIV epidemic is characterized by the co-circulation of subtype B and BF recombinant viral variants. Nef is an HIV protein highly variable among subtypes, making it a good tool to study the impact of HIV variability in the vaccine design setting. We have previously reported a specif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodríguez, Ana María, Pascutti, María Fernanda, Maeto, Cynthia, Falivene, Juliana, Holgado, María Pía, Turk, Gabriela, Gherardi, María Magdalena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360004/ https://www.ncbi.nlm.nih.gov/pubmed/22655069 http://dx.doi.org/10.1371/journal.pone.0037801

Ejemplares similares

IL-12 plus CTB in intranasal DNA-MVA schemes improved magnitude and quality of both systemic and mucosal HIV cellular immune responses
por: Rodriguez, AM, et al.
Publicado: (2012)

T-Cell Immune Responses Against Env from CRF12_BF and Subtype B HIV-1 Show High Clade-Specificity that Can Be Overridden by Multiclade Immunizations
por: Mónaco, Daniela C., et al.
Publicado: (2011)

Novel Mucosal DNA-MVA HIV Vaccination in Which DNA-IL-12 Plus Cholera Toxin B Subunit (CTB) Cooperates to Enhance Cellular Systemic and Mucosal Genital Tract Immunity
por: Maeto, Cynthia, et al.
Publicado: (2014)

Deletion of A44L, A46R and C12L Vaccinia Virus Genes from the MVA Genome Improved the Vector Immunogenicity by Modifying the Innate Immune Response Generating Enhanced and Optimized Specific T-Cell Responses
por: Holgado, María Pía, et al.
Publicado: (2016)

Improving the MVA Vaccine Potential by Deleting the Viral Gene Coding for the IL-18 Binding Protein
por: Falivene, Juliana, et al.
Publicado: (2012)

The HIV-1 epidemic in Bolivia is dominated by subtype B and CRF12_BF "family" strains
por: Guimarães, Monick L, et al.
Publicado: (2012)

Analysis of the Origin and Evolutionary History of HIV-1 CRF28_BF and CRF29_BF Reveals a Decreasing Prevalence in the AIDS Epidemic of Brazil
por: Ristic, Natalia, et al.
Publicado: (2011)

Correction: Analysis of the Origin and Evolutionary History of HIV-1 CRF28_BF and CRF29_BF Reveals a Decreasing Prevalence in the AIDS Epidemic of Brazil
por: Ristic, Natalia, et al.
Publicado: (2011)

Influence of adenovirus and MVA vaccines on the breadth and hierarchy of T cell responses
por: Rollier, Christine S., et al.
Publicado: (2016)

Identification of New HIV-1 Circulating Recombinant Forms CRF81_cpx and CRF99_BF1 in Central Western Brazil and of Unique BF1 Recombinant Forms
por: Reis, Mônica N. G., et al.
Publicado: (2019)

Priming with Recombinant BCG Expressing HTI Enhances the Magnitude and Breadth of the T-Cell Immune Responses Elicited by MVA.HTI in BALB/c Mice
por: Saubi, Narcís, et al.
Publicado: (2020)

Identification of CRF89_BF, a new member of an HIV-1 circulating BF intersubtype recombinant form family widely spread in South America
por: Delgado, Elena, et al.
Publicado: (2021)

Viruses Previously Identified in Brazil as Belonging to HIV-1 CRF72_BF1 Represent Two Closely Related Circulating Recombinant Forms, One of Which, Designated CRF122_BF1, Is Also Circulating in Spain
por: Cañada-García, Javier E., et al.
Publicado: (2022)

Th17 and Th17/Treg ratio at early HIV infection associate with protective HIV-specific CD8(+) T-cell responses and disease progression
por: Falivene, Juliana, et al.
Publicado: (2015)

Author Correction: Identification of CRF89_BF, a new member of an HIV-1 circulating BF intersubtype recombinant form family widely spread in South America
por: Delgado, Elena, et al.
Publicado: (2021)

IL-12 DNA Displays Efficient Adjuvant Effects Improving Immunogenicity of Ag85A in DNA Prime/MVA Boost Immunizations
por: Morelli, María Paula, et al.
Publicado: (2020)

Phylodynamics of HIV-1 Circulating Recombinant Forms 12_BF and 38_BF in Argentina and Uruguay
por: Bello, Gonzalo, et al.
Publicado: (2010)

The Origin, Epidemiology, and Phylodynamics of Human Immunodeficiency Virus Type 1 CRF47_BF
por: Hill, Gracelyn, et al.
Publicado: (2022)

Optimizing DC Vaccination by Combination With Oncolytic Adenovirus Coexpressing IL-12 and GM-CSF
por: Zhang, Song-Nan, et al.
Publicado: (2011)

Identification of CRF66_BF, a New HIV-1 Circulating Recombinant Form of South American Origin
por: Bacqué, Joan, et al.
Publicado: (2021)

Characterization of HIV-1 CRF90_BF1 and putative novel CRFs_BF1 in Central West, North and Northeast Brazilian regions
por: Reis, Mônica Nogueira da Guarda, et al.
Publicado: (2017)

Impact of HIV-ART on the restoration of Th17 and Treg cells in blood and female genital mucosa
por: Caruso, María Paula, et al.
Publicado: (2019)

GM-CSF in inflammation
por: Hamilton, John A.
Publicado: (2019)

G-CSF and GM-CSF Modify Neutrophil Functions at Concentrations found in Cystic Fibrosis
por: Castellani, Stefano, et al.
Publicado: (2019)

G-CSF and GM-CSF in clinical trials.
por: Antman, K. H.
Publicado: (1990)

P18-12 LB. Phase I clinical trial with a new recombinant MVA-BN(®)-multiantigen vaccine: high responder rate and considerable breadth of immunological response
por: Overton, T, et al.
Publicado: (2009)

HIV envelope antigen valency on peptide nanofibers modulates antibody magnitude and binding breadth
por: Fries, Chelsea N., et al.
Publicado: (2021)

Pharmacokinetics of combined gene therapy expressing constitutive human GM-CSF and hyperthermia-regulated human IL-12
por: Wei, Fang, et al.
Publicado: (2013)

Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders
por: Lazarus, Hillard M., et al.
Publicado: (2023)

A role for G-CSF and GM-CSF in nonmyeloid cancers
por: Aliper, Alexander M, et al.
Publicado: (2014)

GM-CSF co-expressing DNA/MVA vaccine, prevention of acquisition by two series of SIVE660 challenges followed by a series of SIV251 challenges
por: Robinson, H, et al.
Publicado: (2012)

Recent Transmission Clustering of HIV-1 C and CRF17_BF Strains Characterized by NNRTI-Related Mutations among Newly Diagnosed Men in Central Italy
por: Fabeni, Lavinia, et al.
Publicado: (2015)

GM-CSF-Dependent Inflammatory Pathways
por: Hamilton, John A.
Publicado: (2019)

Neutralization and clearance of GM-CSF by autoantibodies in pulmonary alveolar proteinosis
por: Piccoli, Luca, et al.
Publicado: (2015)

Increased Breadth and Depth of Cytotoxic T Lymphocytes Responses against HIV-1-B Nef by Inclusion of Epitope Variant Sequences
por: Rolland, Morgane, et al.
Publicado: (2011)

Development of Dendritic Cells from GM-CSF(-/-) Mice in vitro : GM-CSF Enhances Production and Survival of Cells
por: Ni, Keping, et al.
Publicado: (2001)

Innate Immune Modulation by GM-CSF and IL-3 in Health and Disease
por: Borriello, Francesco, et al.
Publicado: (2019)

Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL12
por: Rigo, Antonella, et al.
Publicado: (2010)

Env-Specific IgA from Viremic HIV-Infected Subjects Compromises Antibody-Dependent Cellular Cytotoxicity
por: Ruiz, María Julia, et al.
Publicado: (2015)

Response to Treatment with TNFα Inhibitors in Rheumatoid Arthritis Is Associated with High Levels of GM-CSF and GM-CSF(+) T Lymphocytes
por: Bystrom, Jonas, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hov3lm5apbjop1ed90nq4gh3sp